Methods for treating apnea, apnea disorders, bulimia, and other

Details Methods for treating apnea, apnea disorders, bulimia, and other Methods for treating apnea, apnea disorders, bulimia, and other

1999-06-14

2000-04-11

Cook, Rebecca

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31445

Patent

active

060488794

ABSTRACT:
Methods for the prevention, treatment or management of apnea, apnea disorders, bulimia nervosa, irritable bowel syndrome, urinary incontinence, bradycardia, bradyarrhythmia, syncope, other disorders, or symptoms thereof using (+) norcisapride, or a pharmaceutically acceptable salt thereof, substantially free of its (-) stereoisomer.

REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4598123 (1986-07-01), Cutter
patent: 4962115 (1990-10-01), Van Daele
patent: 5057427 (1991-10-01), Wald et al.
patent: 5057525 (1991-10-01), Van Daele
patent: 5059595 (1991-10-01), Le Grazie
patent: 5073543 (1991-12-01), Marshall et al.
patent: 5075290 (1991-12-01), Findley et al.
patent: 5077217 (1991-12-01), Matson et al.
patent: 5120548 (1992-06-01), McClelland et al.
patent: 5137896 (1992-08-01), Van Daele
patent: 5354556 (1994-10-01), Sparks et al.
patent: 5356934 (1994-10-01), Robertson et al.
patent: 5407953 (1995-04-01), Morgan
patent: 5422374 (1995-06-01), Miyao et al.
patent: 5502067 (1996-03-01), Morgan
patent: 5591767 (1997-01-01), Mohr et al.
patent: 5639476 (1997-06-01), Oshlack et al.
patent: 5663173 (1997-09-01), Jegham et al.
patent: 5674533 (1997-10-01), Santus et al.
patent: 5733566 (1998-03-01), Lewis
patent: 5739151 (1998-04-01), McCullough et al.
Burstein et al., "Structure-Function of Muscarinic Receptor Coupling to G Proteins," J. Biol. Chem., 270:3141-3146 (1995).
Messier, T.L., et al., "High Throughput Assays of Cloned Adrenergic, Muscarinic, Neurokinin, and Neurotrophin Receptors in Living Mammalian Cells," Pharmacol. Toxicol., 76(5):308-311 (1995).
Faris, P.L. et al., "Nociceptive, but not Tactile, Thresholds are Elevated in Bulimia Nervosa," Biol. Psychiatry 32:462-466 (1992).
Schapira, M. et al., "The Current Status of Gastric Prokinetic Drugs," Acta Gastroenterolog. Belg., 53:446-457 (1990).
Dumuis et al., "The Gastrointestinal Prokinetic Benzamide Derivatives are agonists at the non-classical 5-HT receptor (5-HT.sub.4) Positively Cpupled To Adenylate Cyclase In Neurons," N.S. Arch Pharmacol., 340:403-410 (1989).
Clarke et al., "The 5-HT.sub.4 Receptor: Naughty, But Nice," Trends in Pharmacological Sciences, 10:385-386 (1989).
Barnes et al., "Identification of 5-HT.sub.3 Recognition Sites In The Ferret Area Postrema," J. Pharm. Pharmacol., 40:586-588 (1988).
Meuldermans, et al., "Excretion and Biotransformation of Cisapride In Dogs and Humans After Oral Administration," Drug Metab. Dispos., 16(3): 403-409 (1988).
Meuldermans, et al., "Excretion and Biotransformation of Cisapride in Rats After Oral Administration," Drug Metab. Dispos., 16(3):410-419 (1988).
Costall B. et al., "Emesis Induced By Cisplatin In The Ferret As A Model For The Detection Of Anti-Emetic Drugs," Neuropharmacology, 26:1321-1326 (1987).
Van Peer et al., "Clinical Pharmacokinetics of Cisapride," Excerpta Medica, Current Clinical Practice Series, A.G. Johnson and G. Lux, Eds. Amsterdam, 48:23-29 (1988).
Van Daele et al., "Synthesis of Cisapride, a Gastrointentestinal Stimulant Derived From Cis-4-Amino-3-Methoxypiperidine," Drug Development Res., 8:225-232 (1986).
Ebert, W.R., "Soft Elastic Gelatin Capsules: A Unique Dosage Form," Pharm. Tech., 1(5):44-50 (1977).

Affiliated with

Also associated with

Rating

Methods for treating apnea, apnea disorders, bulimia, and other does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treating apnea, apnea disorders, bulimia, and other , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating apnea, apnea disorders, bulimia, and other will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1176946